We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+6.62%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$111B
AUM Growth
+$10.5B
Cap. Flow
+$4.07B
Cap. Flow %
3.67%
Top 10 Hldgs %
16.5%
Holding
4,333
New
263
Increased
1,254
Reduced
2,016
Closed
548

Sector Composition

Rank Sector Weight
1 Financials 11.15%
2 Technology 9.78%
3 Healthcare 9.21%
4 Consumer Discretionary 6.76%
5 Consumer Staples 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TOVX icon
3576
Theriva Biologics
TOVX
$10.1M
$10K ﹤0.01%
2
-2
-50% -$14K
DYN.WS
3577
CALL
DELISTED
Dynegy Inc,
DYN.WS
$10K ﹤0.01%
262,097
KMI.WS
3578
CALL
DELISTED
Kinder Morgan Inc
KMI.WS
$8K ﹤0.01%
4,154,276
+838,995
+25% +$3.61K
GCVRZ
3579
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$8K ﹤0.01%
16,888
C.WS.A
3580
CALL
DELISTED
Citigroup Inc
C.WS.A
$5K ﹤0.01%
35,662
+18,062
+103% +$2.94K
AAL icon
3581
CALL
American Airlines Group
AAL
$9.82B
-125,000
Closed -$5.84M
AAL icon
3582
PUT
American Airlines Group
AAL
$9.82B
-100,000
Closed -$4.67M
AB icon
3583
AllianceBernstein
AB
$3.47B
-42,280
Closed -$992K
ACLS icon
3584
Axcelis
ACLS
$3.44B
-14,458
Closed -$210K
ACM icon
3585
CALL
Aecom
ACM
$9.46B
-47,500
Closed -$1.73M
ACRE
3586
Ares Commercial Real Estate
ACRE
$247M
-13,787
Closed -$189K
ACTG icon
3587
Acacia Research
ACTG
$437M
-33,292
Closed -$217K
ADUS icon
3588
Addus HomeCare
ADUS
$2.22B
-39,994
Closed -$1.4M
ADVM
3589
DELISTED
Adverum Biotechnologies
ADVM
-1,198
Closed -$35K
AER icon
3590
CALL
AerCap
AER
$23.4B
-1,027,700
Closed -$42.8M
AER icon
3591
PUT
AerCap
AER
$23.4B
-11,500
Closed -$479K
AGG icon
3592
iShares Core US Aggregate Bond ETF
AGG
$138B
-3,050
Closed -$330K
AGYS icon
3593
Agilysys
AGYS
$3.21B
-10,529
Closed -$110K
AKAM icon
3594
PUT
Akamai
AKAM
$15.6B
-14,500
Closed -$967K
AKBA icon
3595
Akebia Therapeutics
AKBA
$338M
-20,182
Closed -$210K
ALT icon
3596
Altimmune
ALT
$568M
-263
Closed -$256K
ALTO icon
3597
Alto Ingredients
ALTO
$338M
-90,215
Closed -$858K
ARCT icon
3598
Arcturus Therapeutics
ARCT
$165M
-1,972
Closed -$29K
ASC icon
3599
Ardmore Shipping
ASC
$683M
-12,203
Closed -$90K
ASR icon
3600
Grupo Aeroportuario del Sureste
ASR
$8.16B
-14,005
Closed -$2.02M

Similar funds

Credit Suisse's Q1 2017 Portfolio in Review

As of Q1 2017, Credit Suisse held 4,333 positions worth $111B, up 10% from $100B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Credit Suisse deployed $4.07B of net new capital in Q1 2017, opening 263 new positions and adding to 1,254 existing holdings. Its largest new stake was Qiagen: 1,270,687 shares worth $39M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Cognizant, an estimated $308M trimmed.

  • Credit Suisse's largest Q1 2017 buy was Qiagen: 1,270,687 shares worth $39M.
  • Credit Suisse added most to Reynolds American Inc in Q1 2017, an estimated $754M increase.
  • Credit Suisse's biggest Q1 2017 reduction was Cognizant, cutting an estimated $308M.
  • Credit Suisse fully exited Bats Global Markets, Inc. in Q1 2017, selling an estimated $190M.
  • Credit Suisse's ten largest holdings make up 17% of its $111B portfolio in Q1 2017.
  • Credit Suisse opened 263 new positions and closed 548 in Q1 2017.
  • Credit Suisse's portfolio value rose 10% quarter-over-quarter to $111B.

Based on Credit Suisse's 13F filing for Q1 2017, filed 15 May 2017.